|Publication number||US7615050 B2|
|Application number||US 11/168,234|
|Publication date||Nov 10, 2009|
|Filing date||Jun 27, 2005|
|Priority date||Jun 27, 2005|
|Also published as||US20060293738, US20100042098, US20140221992, WO2007001741A1|
|Publication number||11168234, 168234, US 7615050 B2, US 7615050B2, US-B2-7615050, US7615050 B2, US7615050B2|
|Inventors||Jeffrey M. Cross, Paul DiCarlo|
|Original Assignee||Boston Scientific Scimed, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (31), Non-Patent Citations (3), Referenced by (3), Classifications (14), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The field of the invention relates to medical devices, and more particularly, to medical devices and methods of their use for treating tumors or other targeted bodily tissue using electrical energy.
Tissue may be destroyed, ablated, or otherwise treated using thermal energy during various therapeutic procedures. Many forms of thermal energy may be imparted to tissue, such as radio frequency electrical energy, microwave electromagnetic energy, laser energy, acoustic energy, or thermal conduction.
In particular, radio frequency ablation (RFA) may be used to treat patients with tissue anomalies, such as liver anomalies and many primary cancers, such as cancers of the stomach, bowel, pancreas, kidney and lung. RFA treatment involves the destroying undesirable cells by generating heat through agitation caused by the application of alternating electrical current (radio frequency energy) through the tissue.
Various RF ablation devices have been suggested for this purpose. For example, U.S. Pat. No. 5,855,576 describes an ablation apparatus that includes a plurality of wire electrodes. Each of the wires includes a proximal end that is coupled to a generator; and a distal end that may project from a distal end of a cannula. The wires are arranged in an array with the distal ends located generally radially and uniformly spaced apart from the catheter distal end. The wires may be energized in a monopolar or bipolar configuration to heat and necrose tissue within a precisely defined volumetric region of target tissue. The current may flow between closely spaced wire electrodes (bipolar mode) or between one or more wire electrodes and a larger, common electrode (monopolar mode) located remotely from the tissue to be heated. To assure that the target tissue is adequately treated and/or to limit damaging adjacent healthy tissues, the array of wires may be arranged uniformly, e.g., substantially evenly and symmetrically spaced-apart so that heat is generated uniformly within the desired target tissue volume. Such devices may be used either in open surgical settings, in laparoscopic procedures, and/or in percutaneous interventions.
Currently, tumor near a vessel may be difficult to ablate. This is because the vessel continuously provide blood to the tumor during an ablation procedure, thereby carrying heat away from a targeted region. As a result, it may be difficult to achieve a complete burn for the tumor near the vessel.
In accordance with some embodiments, a method of treating a tissue region includes inserting a flexible sheath within a vessel, the vessel leading to a tissue region, placing a distal end of the sheath through a wall of the vessel to thereby position the distal end at or adjacent the tissue region, deploying a plurality of electrodes from the distal end of the sheath such that tips of the deployed electrodes approximately face towards a proximal end, and delivering energy to at least a portion of the tissue region using the deployed electrodes.
In accordance with other embodiments, a system for treating tissue within a tissue region using electrical energy includes a flexible sheath having a proximal end, a distal end, and a body extending between the proximal and the distal ends, wherein the body is sized such that it can be placed within a blood vessel, and has a length such that when placed within the blood vessel, the proximal end is outside a patient's body and the distal end is adjacent the tissue region, and an array of electrodes slidably disposed within a lumen of the sheath, wherein the sheath further has a sharp distal tip for puncturing a vessel.
In other embodiments, a system for treating tissue within a tissue region using electrical energy includes a flexible sheath having a proximal end, a distal end, and a body extending between the proximal and the distal ends, wherein the body is sized such that it can be placed within a blood vessel, and has a length such that when placed within the blood vessel, the proximal end is outside a patient's body and the distal end is adjacent the tissue region, a shaft having a body, the body having a wall and a plurality of openings through the wall, and an array of electrodes coupled to the shaft, and slidably disposed within a lumen of the sheath.
Other aspects and features will be evident from reading the following detailed description of the embodiments.
The drawings illustrate the design and utility of the illustrated embodiments, in which similar elements are referred to by common reference numerals. In order to better appreciate how advantages and objects of the embodiments are obtained, a more particular description of the embodiments is illustrated in the accompanying drawings.
The generator 12 is preferably capable of operating with a fixed or controlled voltage or current so that power and current diminish as impedance of the tissue being ablated increases. Exemplary generators are described in U.S. Pat. No. 6,080,149, the disclosure of which is expressly incorporated by reference herein. The preferred generator 12 may operate at relatively low fixed voltages, typically below one hundred fifty volts (150 V) peak-to-peak, and preferably between about fifty and one hundred volts (50-100 V). Such radio frequency generators are available from Boston Scientific Corporation, assignee of the present application, as well as from other commercial suppliers. It should be noted that the generator 12 is not limited to those that operate at the range of voltages discussed previously, and that generators capable of operating at other ranges of voltages may also be used.
In the illustrated embodiments, the sheath 52 has a length between about forty and one hundred and thirty centimeters (40-130 cm), and more preferably, between sixty and eighty (60-80 cm). Also, the sheath 52 has an outer diameter or cross sectional dimension between about one and five millimeters (1-5 mm), and more preferably, between two and four millimeters (2-4 mm). In one implementation, the sheath 52 is configured (e.g., sized and shaped) such that it can be inserted within a vessel (e.g., a jugular vein), and that a body of the cannula 52 can extend between a proximal end 72 located outside a patient's body and a distal end 70 located at or adjacent a target region, e.g., a liver, when the sheath 52 is inserted into a jugular vein. In other embodiments, the sheath 52 may also have other lengths and outer cross sectional dimensions, depending upon the application. The sheath 52 may be formed from a polymer, and the like, as long as it is sufficiently flexible for allowing the sheath 52 to be steered through a vessel. The sheath 52 may be electrically active or inactive, depending upon the manner in which electrical energy is to be applied.
The sheath 52 coaxially surrounds the shaft 56 such that the shaft 56 may be advanced axially from or retracted axially into the lumen 54 of the sheath 52. The shaft 56 can be made from any of a variety of elastic materials, such as a polymer, or a metal, as long as it is sufficiently elastic to be steered through a vessel. For example, the shaft 56 can be a Nitinol tube having a plurality of openings 57 for providing a desired flexibility for the tube, which is available at Boston Scientific Corporation, the Precision Vascular Division. In other cases, instead of being a tube, the shaft 56 can have a solid cross-section. Optionally, a handle 64 may be provided on the proximal end 58 of the shaft 56 to facilitate manipulating the shaft 56. The electrode tines 62 are compressed into a low profile when disposed within the lumen 54 of the sheath 52, as shown in
Optionally, a marker (not shown) may be placed on the handle 64 and/or on the proximal end 58 of the shaft 56 for indicating a rotational orientation of the shaft 56 during use. In other embodiments, the ablation assembly 50 may also carry one or more radio-opaque markers (not shown) to assist positioning the ablation assembly 50 during a procedure, as is known in the art. For example, in some embodiments, the ablation assembly 50 may further include a radio opaque marker located at a distal end 70 of the sheath 52 or the shaft 56. Alternatively or additionally, one or more of the electrode tines 62 may each carry a radio opaque element (e.g., a marker). Optionally, the ablation assembly 50 may also include a sensor, e.g., a temperature sensor and/or an impedance sensor (not shown), carried by the distal end of the shaft 56 and/or one or more of the electrode tines 62. In such cases, the energy source 12 may be configured to control an amount of energy delivered to the electrode tines 62 based at least in part on a signal provided by the sensor.
In the illustrated embodiments, the ablation assembly 50 further include a steering mechanism 80 secured to the proximal end 72 of the sheath 52 for steering a distal end 70 of the sheath 52. The steering mechanism 80 includes a rotatable cam and one or more steering wires (not shown) connected between the cam and the distal end 70 of the sheath 52. During use, the cam can be rotated to apply tension to a steering wire, thereby causing the distal end 70 of the sheath 52 to bend. Further details regarding the steering mechanism 80 are described in U.S. Pat. No. 5,273,535, the entire disclosure of which is herein incorporated by reference. Steering devices that can be used with the ablation assembly 50 have also been described in U.S. Pat. Nos. 5,254,088, 5,336,182, 5,358,478, 5,364,351, 5,395,327, 5,456,664, 5,531,686, 6,033,378, and 6,485,455, the entire disclosures of which are expressly incorporated by reference herein.
In other embodiments, the ablation assembly 50 does not include the steering mechanism 80. In such cases, a separate introducer sheath or introducer catheter may be used to gain access through a vessel. The introducer sheath may have a pre-bent distal end for assisting steering through a vessel. Alternatively, the introducer sheath may be steered using a guidewire in a conventional manner, or may include a steering mechanism, such as the steering mechanism 80 discussed previously, for steering its distal end. In some embodiments, the introducer sheath/catheter can have a sharp distal tip for piercing tissue.
In other embodiments, the ablation assembly 50 can include a guidewire (not shown) to assist placement of the distal end 70 of the sheath 52 in a conventional manner. The guidewire may be located within the lumen 54 of the sheath 52, or alternatively, located within another lumen (not shown) in the sheath 52 that is parallel to the lumen 54.
It should be noted that the ablation device 18 is not necessarily limited to the ablation assembly 50 shown in
In the illustrated embodiments, the ablation assembly 50 also includes an electrode 90 secured to the sheath 52. A wire (not shown) may be disposed within the wall of the sheath 52 to electrically couple the electrode 90 to the generator 12 during use. The electrode 90 and the array of electrodes 62 are connected to opposite terminals of the generator 12 for delivering energy to target tissue in a bipolar mode. In other embodiments, the ablation assembly 50 does not include the electrode 90 (
Referring now to
In other embodiments, instead of using an introducer sheath/catheter 100, if the ablation assembly 50 includes the steering mechanism 80, the ablation assembly 50 can be inserted through a patient's skin and into the vessel V, and be steered to a desired location at or adjacent to the target region TR. In one implementation, a transjugular approach may be used, in which the distal end 70 is inserted through a jugular vein in the patient's neck. After the distal end 70 of the sheath 52 has been inserted through the patient's skin, the distal end 70 is then steered to the tissue T, such as a liver tissue, through the vessel V. The sheath 52 may be steered by using the guidewire in a conventional manner, or by applying tension to steering wire(s) (if the steering mechanism 80 is provided). If the sheath 52 has a sharp distal tip, it can be used to puncture the vessel V to allow the distal end 70 of the sheath 52 to gain access to the target region TR. In other embodiments, a separate puncturing device, such as a wire or a needle, can be inserted through the sheath 52 to puncture the vessel V.
Next, energy, preferably RF electrical energy, may be delivered from the generator 12 to the wires 62 of the ablation device 18, thereby substantially creating a lesion at the target tissue TS of the treatment region TR. If the system of
When a desired lesion at the target tissue TS of the treatment region TR has been created, the electrode tines 62 of the ablation device 18 may be retracted into the lumen 54 of the sheath 52, and the ablation device 18 may be removed from the treatment region TR. In some cases, the entire treatment region TR may be ablated in a single pass. In other cases, if it is desired to perform further ablation to increase the lesion size or to create lesions at different site(s), e.g., at other target tissue TS, within the treatment region TR or elsewhere, the electrode tines 62 of the ablation device 18 may be introduced and deployed at different target site(s), and the same steps discussed previously may be repeated.
Although particular embodiments have been shown and described, it will be understood that it is not intended to limit the present inventions to the preferred embodiments, and it will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present inventions. For example, the electrode tines 62 may be a single electrode made from a plurality of conductive components, or a plurality of electrodes. As such, the term, “a plurality of electrodes” should not be limited to more than one electrode, and may include a single electrode having a plurality of conductive components/parts. The specification and drawings are, accordingly, to be regarded in an illustrative rather than restrictive sense. The present inventions are intended to cover alternatives, modifications, and equivalents, which may be included within the spirit and scope of the present inventions as defined by the claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US5254088||Dec 16, 1992||Oct 19, 1993||Ep Technologies, Inc.||Catheter steering mechanism|
|US5273535||Nov 8, 1991||Dec 28, 1993||Ep Technologies, Inc.||Catheter with electrode tip having asymmetric left and right curve configurations|
|US5336182||Jul 30, 1993||Aug 9, 1994||Ep Technologies, Inc.||Catheter steering mechanism|
|US5358478||May 6, 1993||Oct 25, 1994||Ep Technologies, Inc.||Catheter steering assembly providing asymmetric left and right curve configurations|
|US5364351||Nov 13, 1992||Nov 15, 1994||Ep Technologies, Inc.||Catheter steering mechanism|
|US5395327||Jul 30, 1993||Mar 7, 1995||Ep Technologies, Inc.||Catheter steering mechanism|
|US5456664||Nov 14, 1994||Oct 10, 1995||Ep Technologies, Inc.||Catheter steering mechanism|
|US5531686||Dec 23, 1994||Jul 2, 1996||Ep Technologies, Inc.||Catheter steering mechanism|
|US5536240 *||Sep 27, 1994||Jul 16, 1996||Vidamed, Inc.||Medical probe device and method|
|US5707350 *||Apr 22, 1996||Jan 13, 1998||Smith & Nephew Endoscopy Inc.||Surgical instrument|
|US5855576||Dec 12, 1996||Jan 5, 1999||Board Of Regents Of University Of Nebraska||Method for volumetric tissue ablation|
|US5906606 *||Feb 27, 1996||May 25, 1999||Target Therapuetics, Inc.||Braided body balloon catheter|
|US6033378||Mar 27, 1997||Mar 7, 2000||Ep Technologies, Inc.||Catheter steering mechanism|
|US6080149||Jan 9, 1998||Jun 27, 2000||Radiotherapeutics, Corporation||Method and apparatus for monitoring solid tissue heating|
|US6283951 *||Mar 25, 1998||Sep 4, 2001||Transvascular, Inc.||Systems and methods for delivering drugs to selected locations within the body|
|US6287304 *||Oct 15, 1999||Sep 11, 2001||Neothermia Corporation||Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes|
|US6485455||Mar 19, 1999||Nov 26, 2002||Ep Technologies, Inc.||Catheter steering assembly providing asymmetric left and right curve configurations|
|US6500175 *||Jan 20, 2000||Dec 31, 2002||Rita Medical Systems, Inc.||Multiple antenna ablation apparatus and method with cooling element|
|US7317950 *||Feb 24, 2003||Jan 8, 2008||The Regents Of The University Of California||Cardiac stimulation system with delivery of conductive agent|
|US20030060817 *||Aug 30, 2002||Mar 27, 2003||Scimed Life Systems, Inc.||Percutaneous pringle occlusion method and device|
|US20030212394 *||May 10, 2002||Nov 13, 2003||Rob Pearson||Tissue ablation apparatus and method|
|US20040098075 *||Feb 24, 2003||May 20, 2004||The Regents Of The University Of California||Cardiac stimulation system and method|
|US20040236360 *||Nov 14, 2003||Nov 25, 2004||Trans Vascular, Inc.||Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo|
|US20050020965 *||Aug 25, 2004||Jan 27, 2005||Scimed Life Systems, Inc.||Devices and methods for delivering agents to tissue region while preventing leakage|
|US20050234399 *||Apr 19, 2004||Oct 20, 2005||Searete Llc, A Limited Liability Corporation Of The State Of Delaware||System for perfusion management|
|US20060089635 *||Oct 22, 2004||Apr 27, 2006||Scimed Life Systems, Inc.||Methods and apparatus for focused bipolar tissue ablation using an insulated shaft|
|US20060154884 *||Jun 18, 2003||Jul 13, 2006||Arnd Buchwald||Use of a vegf receptor gener or gene product|
|US20060217704 *||Feb 6, 2006||Sep 28, 2006||Instrumedical Ltd.||Electro-surgical needle apparatus|
|US20060224154 *||Jan 10, 2006||Oct 5, 2006||Shadduck John H||Medical instrument and method of use|
|EP0628288A2||May 12, 1994||Dec 14, 1994||Vidamed, Inc.||Medical probe|
|GB2313062A||Title not available|
|1||PCT International Preliminary Report on Patentability for PCT/US2006/021715, Applicant: Boston Scientific Scimed, Inc., Form PCT/IB/326, dated Jan. 17, 2008 (6 pages).|
|2||PCT International Search Report for PCT/US2006/021715, Applicant: Boston Scientific Scimed, Inc., Form PCT/ISA/210 and 220, dated Nov. 21, 2006(5 pages).|
|3||PCT Written Opinion of the International Search Authority for PCT/US2006/021715, Applicant: Boston Scientific Scimed, Inc., Form PCT/ISA/237, dated Nov. 21, 2006 (4 pages).|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8974454 *||Dec 30, 2010||Mar 10, 2015||St. Jude Medical, Atrial Fibrillation Division, Inc.||Kit for non-invasive electrophysiology procedures and method of its use|
|US8979837||Dec 31, 2009||Mar 17, 2015||St. Jude Medical, Atrial Fibrillation Division, Inc.||Flexible tip catheter with extended fluid lumen|
|US20110288392 *||Dec 30, 2010||Nov 24, 2011||De La Rama Alan||Kit for Non-Invasive Electrophysiology Procedures and Method of its Use|
|U.S. Classification||606/41, 606/167|
|Cooperative Classification||A61B2018/1475, A61B2018/1425, A61B2018/00404, A61B18/1477, A61B18/1492, A61B2018/00577, A61B18/00, A61B2018/00345, A61B2018/0016, A61B2018/143|
|Jun 27, 2005||AS||Assignment|
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CROSS, JEFFREY M.;DICARLO, PAUL;REEL/FRAME:016736/0595
Effective date: 20050615
|Oct 19, 2010||CC||Certificate of correction|
|Mar 7, 2013||FPAY||Fee payment|
Year of fee payment: 4